Preliminary Scientific Program

IPTA 5th Congress Registration Brochure

Download a copy of the Preliminary Program with Abstract Presentations

Saturday, April 18, 2009
8:30 AM - 3:30 PM IPTA Post Graduate Course
8:30 AM - 12:00 PM Quality of Life
Supported in part by the Dr. Ken Citron Memorial Foundation
8:30 AM - 9:00 AM When is a Patient too Sick to be (Re)transplanted? Ethical Considerations in Times of Long Waiting Lists.
Alan R. Watson, UK
9:00 AM - 9:30 AM The Role of the Psychosocial Team in Decision-Making Around Transplantation: the Good, the Bad or the Necessity
Jo Wray, UK
9:30 AM - 10:00 AM Ingredients for a Successful Transition from Pediatric to Adult Care
Debra S. Lefkowitz and Karen McCandless, USA
10:00 AM - 10:30 AM Break
10:30 AM - 11:00 AM Cultural Challenges in Pediatric Care: Transplantation in a Multicultural Society
Cate Fraser-Irwin, New Zealand
11:00 AM - 11:30 AM Cultural Challenges in Pediatric Care: Transplantation in the Developing World
Jameela Abdulaziz Kari, Saudi Arabia
11:30 AM - 12:00 PM Quality of Life: Which Measurement Instruments are Appropriate?
Rachel M. Taylor, UK
12:00 PM - 1:00 PM Lunch
1:00 PM - 3:30 PM Vaccines and Viruses in Transplant Recipients
1:00 PM - 1:30 PM BK Virus
Vikas R. Dharnidharka, USA
1:30 PM - 2:00 PM Adenoviral Infection in Transplant Patients
Jill A. Hoffman, USA
2:00 PM - 2:30 PM Break
2:30 PM - 3:00 PM Immunization Practices: Implementation and Delivery of Vaccines
Klara M. Posfay-Barbe, Switzerland
3:00 PM - 3:30 PM Immunization Practices: Newer Vaccines and Their Role in Pediatric Transplant Recipients
Anita Verma, UK
5:00 PM - 5:30 PM Welcome Address
5:30 PM - 6:30 PMPlenary Session I: Non-adherence
5:30 PM - 5:45 PM Can it be Predicted?
Fabienne Dobbels, Belgium
5:45 PM - 6:00 PM Can it be Detected?
Eyal Shemesh, USA
6:00 PM - 6:15 PM Can it be Prevented?
Necla Buyan, Turkey
6:15 PM - 6:30 PM Does it Exclude a Patient for Re-transplantation?
Lars Pape, Germany
6:30 PM - 8:00 PM Welcome Reception
Supported by Astellas
Sunday, April 19, 2009
8:00 AM - 8:30 AM State-of-the-Art Presentation I
Transplantation of Children in Turkey - Historical Perspective
Mehmet Haberal, Turkey
8:30 AM - 10:00 AM Concurrent Sessions I: Abstract Presentations
10:00 AM - 10:30 AM Break
10:30 AM - 11:30 AM Parallel Interactive Workshops I
  • Workshop 1: Recurrence of FSGS (Kidney)
    Aysin Bakkaloglu, Turkey
    Mouin G. Seikaly, USA
  • Workshop 2: Management of the Recipient with Thrombophilia
    Sema Anak, Turkey
    Piotr J. Kalicinski, Poland
  • Workshop 3: Infectious Complications in Developing Countries in Pediatric Solid/Liquid Organ Allograft Recipients
    Anupam Sibal, India
    Upton D. Allen, Canada

    Supported by CSL Behring
11:30 AM - 12:30 PM Debate I: If Immunosuppression is Withdrawn –Therapeutically (PTLD) or Voluntarily (Non-adherence), Should it be Restarted?
  • Pro: Raymond Reding, Belgium
  • Con: Nancy C. Poirier, Canada
12:30 PM - 1:00 PM Lunch
1:00 PM - 2:30 PM Concurrent Sessions II: Abstract Presentations
2:30 PM - 3:30 PM Parallel Interactive Workshops II
  • Workshop 4: Recurrence of HUS
    Chantal Loirat, France
    Jorge R. Ferraris, Argentina
  • Workshop 5: Renal Dysfunction in Renal and Non-renal Solid/Liquid Organ Transplant Recipients: Incidence/Etiology/Risk Factors/Prevention/Treatment
    Guido Filler, Canada
    Ross W. Shepherd, USA
  • Workshop 6: Social Issues Impacting on Long-term Outcome
    Deirdre Anne Kelly, UK
    Jo Wray, UK
3:30 PM - 4:00 PM Break
4:00 PM - 5:00 PM Plenary Session II: Ethical Issues
4:00 PM - 4:15 PM Is a National System Utilizing Unrelated Living Donors Effective?
Hasan Outekesh, Iran
4:15 PM - 4:30 PM What is the Optimal Approach to the Developmentally Challenged Patient?
Robert B. Ettenger, USA
4:30 PM - 4:45 PM Who is Responsible for Continuing Care of the Recipient of Transplant Tourism?
Yaacov Frishberg, Israel
4:45 PM - 5:00 PM Are Current Approaches to Obtaining Informed Consent Optimal?
J. Richard Thistlethwaite, USA
5:00 PM - 5:30 PM Special Lecture
Molecular Diagnosis of Acute Rejection in Kidney and Liver Transplant Recipients
Abraham Shaked, USA
5:30pm – 6:00pm Late Breaking Abstract Presentations
5:30 PM - 7:00 PM Poster Session I - Wine and Cheese Reception
Supported by Astellas
Monday, April 20, 2009
8:00 AM - 8:30 AM State-of-the-Art Presentation II
Will Hepatocytes and Islet Cell Transplants Replace Liver and Pancreas Solid Organ Transplantation?
Anil Dhawan, UK
8:30 AM - 10:00 AM Concurrent Sessions III: Abstract Presentations
10:00 AM - 10:30 AM Break
10:15 AM - 11:15 AM Parallel Interactive Workshops III

Workshop 7: Unique Registry Reports
  • 10:30 AM – 10:42 AM
    Nordic Pediatric Renal Transplant Group
    Sverker Hansson, Sweden
  • 10:42 AM – 10:54 AM
    Latin America Renal Transplant Registry
    Angela Delucchi, Chile
  • 10:54 AM - 11:06 AM
    PLUTO
    Jean-Bernard Otte, Belgium
  • 11:06 AM – 11:18 AM
    Solid Organ Transplant Tolerance Registry
    George V. Mazariegos, USA
  • 11:18 AM – 11:30 AM
    FSGS Recurrence Registry
    Lothar Bernd Zimmerhackl, Austria
  • Workshop 8: Current Management of PTLD
    Vikas R. Dharnidharka, USA
    Michael Green, USA
  • Workshop 9: Optimal Approach to Preventing Potential Long-term Complications of Pediatric Solid/Liquid Organ Allograft Recipients
    Khalid Sharif, UK
    Oguz Soylemezoglu, Turkey
11:15 AM – 11:45 AM Business Meeting
11:45 AM – 12:00 PM Secure Lunch
12:00 PM - 1:00 PM Lunch Symposium
Pediatric Transplantation: How Can We Improve Outcomes?

Supported by Astellas
12:00 PM – 12:05 PM Chairs introduction
Deirdre Kelly, UK
12:05 PM - 12:20 PM Challenges in Pediatric Transplantation
Guido Filler, Canada
12:20 PM - 12:35 PM Safety and Efficacy of Tacrolimus in Pediatric Liver Recipients
Deirdre Kelly, UK
12:35 PM - 12:50 PM Minimizing Steroid Use in Pediatric Kidney Recipients
Ryszard Grenda, Poland
12:50 PM - 1:00 PM Panel discussion
Deirdre Kelly, UK
1:00 PM - 2:30 PM Concurrent Sessions IV: Abstract Presentations
2:30 PM - 3:30 PM Plenary Session III: Registry Reports
2:30 PM - 2:45 PM NAPRTCS
William E. Harmon, USA
2:45 PM - 3:00 PM IITR
Jean de Ville de Goyet, Italy
3:00 PM - 3:15 PM PHTS
Anne I. Dipchand, Canada
3:15 PM - 3:30 PM SPLIT
Sue V. McDiarmid, USA
3:30 PM - 4:00 PM Break
4:00 PM - 5:00 PM Parallel Interactive Workshops IV
  • Workshop 10: What is the Optimal Approach to Drug Monitoring in Pediatric Solid Organ Transplantation?
    Peter F. Hoyer, Germany
    Elias David-Neto, Brazil
  • Workshop 11: Transplantation of Metabolic Diseases
    Cigdem Arikan, Turkey
    Martin M. Burdelski, Germany
  • Workshop 12: Are There Clinical Models of Tolerance that Currently Exist in Pediatric Solid/Liquid Organ Transplant Recipients?
    J. Richard Thistlethwaite, USA
    Carlos O. Esquivel, USA

    Supported by the International Liver Transplantation Society
5:00 PM - 5:30 PM Special Lecture
Pediatric Drug Development - Legislation and the Way Forward
Irmgard Eichler, UK
5:30PM – 6:00PM Late Breaking Abstract Presentations
5:30 PM - 7:00 PM Poster Session II - Wine and Cheese Reception
Tuesday, April 21, 2009
8:00 AM - 8:30 AM Presidential Address
8:30 AM - 9:00 AM State-of-the-Art Presentation III
Are Pre-Transplant Pharmacogenetic Assessment and Determination of Genetic Polymorphisms Ready for Prime Time in Pediatric Solid Organ Transplantation?
Steven A. Webber, USA
9:00 AM - 10:00 AM Plenary Session IV: Organ Allocation
9:00 AM - 9:15 AM UNOS
Ruth A. McDonald, USA
9:15 AM - 9:30 AM Eurotransplant
Burkard Tönshoff, Germany
9:30 AM - 9:45 AM UK Transplant
Richard S. Trompeter, UK
9:45 AM - 10:00 AM French Transplant
Pierre Cochat, France
10:00 AM - 11:00 PM Plenary Session V: Chronic Allograft Dysfunction Prevalence/Pathology/Risk Factors/Prevention/Treatment/Outcomes
10:00 AM - 10:15 AM Kidney
Burkard Tönshoff, Germany
10:15 AM - 10:30 AM Heart
Estela Azeka, Brazil
10:30 AM - 10:45 AM Lung
Albert Faro, USA
10:45 AM - 11:00 AM Liver
Eytan Mor, Israel
11:00 AM - 11:30 AM Break
11:30 AM - 1:00 PM Concurrent Sessions V: Abstract Presentations
1:00 PM - 1:30 PM Lunch
1:30 PM - 2:30 PM

Debate II: Re-transplantation of Any Solid Organ Recipient with a Deceased Donor Graft is Contraindicated Because of the Organ Donor Shortage Unless the Donor is a Living Related Donor?

  • Pro: Steven R. Alexander, USA
  • Con: Kim M. Olthoff, USA
2:30 PM - 3:30 PM Concurrent Sessions VI: Abstract Presentations
3:30 PM - 4:30 PM Young Investigator Award Abstracts
4:30 PM - 5:30 PM Plenary Session VI: What's New/What's Hot
4:30 PM - 5:00 PM Basic Science - Minnie M. Sarwal, USA
5:00 PM - 5:30 PM Clinical - Mark R. Benfield, USA
7:00 PM Gala Dinner
A bust of Richard Fine, MD
Richard Fine, MD

Vice President of IPTA
IPTA Scientific Advisory Committee Chair
A bust of Oguz Soylemezoglu
Oguz Soylemezoglu, MD

Local Organizing Committee Chair